{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:44:20Z","timestamp":1784371460233,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.exppara.2019.107756","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T11:30:03Z","timestamp":1567683003000},"page":"107756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Biological evaluation of newly synthesized quinoline\u2013based compound PPQ-8 in acute and chronic toxoplasmosis: An experimental study"],"prefix":"10.1016","volume":"206","author":[{"given":"Hanan Abd","family":"Elgawad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar M.","family":"Alhusseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Taman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Younis","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Massoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Handousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2019.107756_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/1573406411208030392","article-title":"Four-component synthesis of 1,2-dihydropyridine derivatives and their evaluation as anticancer agents","volume":"8","author":"Abdel-Fattah","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.exppara.2019.107756_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.parint.2017.08.007","article-title":"The effect of lopinavir\/ritonavir and lopinavir\/ritonavir loaded PLGA nanoparticles on experimental toxoplasmosis","volume":"6","author":"Abou-El-Naga","year":"2017","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.exppara.2019.107756_bib3","first-page":"285","article-title":"Transmission and scanning electron microscopy of host cell entry by Toxoplasma gondii","volume":"87","author":"Aikawa","year":"1977","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exppara.2019.107756_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.exppara.2019.107756_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1568005054880172","article-title":"Quinolone-based drugs against Toxoplasma gondii and Plasmodium spp","volume":"5","author":"Anquetin","year":"2005","journal-title":"Curr. Drug Targets - Infect. Disord."},{"key":"10.1016\/j.exppara.2019.107756_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopha.2016.05.041","article-title":"Human toxoplasmosis-Searching for novel chemotherapeutics","volume":"82","author":"Antczak","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exppara.2019.107756_bib7","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/AAC.36.2.326","article-title":"In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii","volume":"36","author":"Araujo","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.exppara.2019.107756_bib8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.sajb.2010.04.009","article-title":"In vitro pharmacological evaluation and phenolic content of ten South African medicinal plants used as anthelmintics","volume":"76","author":"Aremu","year":"2010","journal-title":"S AFR J BOT"},{"issue":"Suppl. 1","key":"10.1016\/j.exppara.2019.107756_bib9","article-title":"Characteristics of compounds that cross the blood-brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC Neurol."},{"key":"10.1016\/j.exppara.2019.107756_bib10","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.exppara.2019.107756_bib11","first-page":"334","article-title":"Toxoplasmosis and pregnancy","volume":"60","author":"Chaudhry","year":"2014","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.exppara.2019.107756_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bmj.321.7254.142","article-title":"Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis","volume":"321","author":"Cook","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.exppara.2019.107756_bib13","doi-asserted-by":"crossref","first-page":"15936","DOI":"10.1073\/pnas.1208069109","article-title":"Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis","volume":"109","author":"Doggett","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.exppara.2019.107756_bib14","doi-asserted-by":"crossref","unstructured":"Dubey, J.P., Jones, J.L., Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol.. 38, 1257-1278. doi: 10.1016\/j.ijpara.2008.03.007. Epub 2008 Apr 11.","DOI":"10.1016\/j.ijpara.2008.03.007"},{"key":"10.1016\/j.exppara.2019.107756_bib15","series-title":"Toxoplasmosis of Animals and Humans","author":"Dubey","year":"2010"},{"key":"10.1016\/j.exppara.2019.107756_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jac\/34.1.111","article-title":"Evaluation of the efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis","volume":"34","author":"Dumas","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2019.107756_bib17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/icb.2011.93","article-title":"Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger","volume":"90","author":"Egan","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.exppara.2019.107756_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exppara.2015.06.005","article-title":"Could miltefosine be used as a therapy for toxoplasmosis?","volume":"157","author":"Eissa","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2019.107756_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ardp.200900222","article-title":"Synthesis and antioxidant activity of new pyridines containing gallate moieties","volume":"9","author":"El-Ebiary","year":"2010","journal-title":"Arch. Pharm. Chem. Life Sci"},{"key":"10.1016\/j.exppara.2019.107756_bib20","first-page":"185","article-title":"Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies","volume":"38","author":"El -Zawawy","year":"2008","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"10.1016\/j.exppara.2019.107756_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exppara.2014.12.007","article-title":"Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis","volume":"149","author":"El-Zawawy","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2019.107756_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(98)00012-6","article-title":"Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents","volume":"79","author":"Foley","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.exppara.2019.107756_bib23","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1128\/IAI.00333-12","article-title":"Infection with Toxoplasma gondii alters lymphotoxin expression associated with changes in splenic architecture","volume":"80","author":"Glatman Zaretsky","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.exppara.2019.107756_bib24","first-page":"1171","article-title":"Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease","volume":"39","author":"Gormley","year":"1998","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exppara.2019.107756_bib25","first-page":"77","article-title":"Toxoplasma gondii: scanning electron microscopic study before and after treatment","volume":"2","author":"Hammouda","year":"1992","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.exppara.2019.107756_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/138945010790711996","article-title":"Halogen atoms in the modern medicinal chemistry: hints for the drug design","volume":"11","author":"Hernandes","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.exppara.2019.107756_bib27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9394(99)00263-9","article-title":"Reconsidering the pathogenesis of ocular toxoplasmosis","volume":"128","author":"Holland","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exppara.2019.107756_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.exppara.2014.08.008","article-title":"The potential of quinoline derivatives for the treatment of Toxoplasma gondii infection","volume":"145","author":"Kadri","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2019.107756_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/IAI.73.1.617-621.2005","article-title":"Interleukin-17\/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection","volume":"73","author":"Kelly","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.exppara.2019.107756_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157018007784620031","article-title":"Target-oriented synthesis of antiparasitic 2-hetaryl substituted quinolines based on imino Diels-Alder reactions","volume":"4","author":"Kouznetsov","year":"2007","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.exppara.2019.107756_bib31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.phymed.2014.02.005","article-title":"Anti-tumour and pharmacokinetics study of 2-Formyl-8-hydroxy-quinolinium chloride as Galipea longiflora alkaloid analogue","volume":"21","author":"Lam","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.exppara.2019.107756_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125705","article-title":"Ciprofloxacin derivatives affect parasite cell division and increase the survival of mice infected with Toxoplasma gondii","volume":"10","author":"Martins-Duarte","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exppara.2019.107756_bib33","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4049\/jimmunol.140.5.1632","article-title":"Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge","volume":"140","author":"McLeod","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2019.107756_bib34","doi-asserted-by":"crossref","first-page":"29179","DOI":"10.1038\/srep29179","article-title":"New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections","volume":"6","author":"McPhillie","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exppara.2019.107756_bib35","first-page":"1","article-title":"Cytotoxicity and molecular targeting study of novel 2-chloro-3- substituted quinoline derivatives as antitumor agents","volume":"15","author":"Mohamed","year":"2018","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.exppara.2019.107756_bib36","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00436-018-6027-z","article-title":"Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review","volume":"117","author":"Montazeri","year":"2018","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.exppara.2019.107756_bib37","doi-asserted-by":"crossref","unstructured":"Muregi, F.W., Ishih, A., Next-Generation antimalarial drugs: hybrid molecules as a new strategy in drug design. Drug Dev. Res.. 71, 20-32. doi: 10.1002\/ddr.20345.","DOI":"10.1002\/ddr.20345"},{"key":"10.1016\/j.exppara.2019.107756_bib38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7861\/clinmedicine.8-5-539","article-title":"Common AIDS-associated opportunistic infections","volume":"8","author":"Ong","year":"2008","journal-title":"Clin. Med."},{"key":"10.1016\/j.exppara.2019.107756_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2015.02.046","article-title":"Synthesis, characterization, and antileishmanial activities of gold(I) complexes involving quinoline functionalized N-heterocyclic carbenes","volume":"94","author":"Paloque","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exppara.2019.107756_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00011-013-0588-1","article-title":"Anti-inflammatory effect of quinoline alkaloid skimmianine isolated from Ruta graveolens L","volume":"62","author":"Ratheesh","year":"2013","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.exppara.2019.107756_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.exppara.2019.107756_bib42","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1016\/j.bmcl.2005.07.044","article-title":"Synthesis and anthelmintic properties of arylquinolines with activity against drug-resistant nematodes","volume":"15","author":"Rossiter","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.exppara.2019.107756_bib43","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1021\/acs.jmedchem.7b01192","article-title":"Inhibition of calcium dependent protein kinase 1 (CDPK1) by pyrazolopyrimidine analogs decreases establishment and reoccurrence of central nervous system disease by Toxoplasma gondii","volume":"60","author":"Rutaganira","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2019.107756_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00431-005-1665-4","article-title":"Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine","volume":"165","author":"Schmidt","year":"2006","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.exppara.2019.107756_bib45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.mib.2013.07.003","article-title":"The metabolic roles of the endosymbiotic organelles of Toxoplasma and Plasmodium spp","volume":"16","author":"Sheiner","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.exppara.2019.107756_bib46","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/AAC.01256-06","article-title":"Quinoline derivative MC1626, a putative GCN5 histone acetyltransferase (HAT) inhibitor, exhibits HAT-Independent activity against Toxoplasma gondii","volume":"51","author":"Smith","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.exppara.2019.107756_bib47","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/clinids\/24.3.422","article-title":"Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone\/Toxoplasmic Encephalitis study group","volume":"24","author":"Torres","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.exppara.2019.107756_bib48","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.bmcl.2013.06.014","article-title":"Evaluation of (4-aminobutyloxy)quinolines as a novel class of antifungal agents","volume":"23","author":"Vandekerckhove","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.exppara.2019.107756_bib49","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1021\/acs.jmedchem.6b00760","article-title":"Development of an orally available and central nervous system (CNS) penetrant Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitor with minimal human ether-a-go-go-related gene (hERG) activity for the treatment of toxoplasmosis","volume":"59","author":"Vidadala","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2019.107756_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.exppara.2019.107756_bib51","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/jm3012068","article-title":"Principles and applications of halogen bonding in medicinal chemistry and chemical biology","volume":"56","author":"Wilcken","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exppara.2019.107756_bib52","doi-asserted-by":"crossref","first-page":"12771","DOI":"10.3390\/molecules171112771","article-title":"Medicinal plants: a source of anti-parasitic secondary metabolites","volume":"17","author":"Wink","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.exppara.2019.107756_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4939-2272-7_3","article-title":"Getting across the cell membrane: an overview for small molecules, peptides, and proteins","volume":"1266","author":"Yang","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exppara.2019.107756_bib54","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/mp.2008.5","article-title":"Are some cases of psychosis caused by microbial agents? A review of the evidence","volume":"5","author":"Yolken","year":"2008","journal-title":"Mol. Psychiatry"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489419301699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489419301699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:25:22Z","timestamp":1758003922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489419301699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":54,"alternative-id":["S0014489419301699"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2019.107756","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological evaluation of newly synthesized quinoline\u2013based compound PPQ-8 in acute and chronic toxoplasmosis: An experimental study","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2019.107756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107756"}}